Metoprolol Al (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, reducing the effects of adrenaline and noradrenaline. This slows the heart rate, lowers myocardial contractility, and decreases cardiac output, which together lower arterial pressure and reduce the heart’s oxygen demand.

The appropriate dose of Metoprolol Al is individualized by the prescribing clinician based on the specific condition being treated, the patient’s age, weight, renal function, and response to therapy. Dosage adjustments are made to achieve therapeutic goals while minimizing side effects.

The pregnancy safety category for Metoprolol Al is not definitively established. Clinicians weigh potential benefits against possible risks before prescribing to pregnant or nursing women. If treatment is considered essential, close monitoring and consultation with obstetric specialists are recommended.

To order Metoprolol Al, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol Al is a selective β1‑blocker with a relatively short half‑life, often requiring twice‑daily dosing, whereas atenolol has a longer half‑life and is usually taken once daily. Both reduce heart rate and blood pressure, but metoprolol may provide more consistent control of angina and post‑MI outcomes, while atenolol is sometimes preferred for its dosing convenience.

Metoprolol Al should be stored below 25 °C in a dry place. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Metoprolol Al is taken orally as a tablet. It can be swallowed with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether the dose should be taken with meals to improve tolerability.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions. Patients should seek immediate medical attention if they experience fainting, severe dizziness, difficulty breathing, or signs of an allergic response.

Metoprolol Al is contraindicated in patients with known hypersensitivity to metoprolol or other beta‑blockers, those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and individuals in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or severe peripheral vascular disease.